Letters

Lipid lowering drugs in diabetes: Lipid lowering has ophthalmic benefits

BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7552.1272-b (Published 25 May 2006) Cite this as: BMJ 2006;332:1272
  1. Hiten G Sheth, specialist registrar (drhitensheth@yahoo.co.uk),
  2. Sher Aslam, senior house officer,
  3. Nigel Davies, consultant
  1. Department of Ophthalmology, Chelsea and Westminster Hospital, London SW10 9NH
  2. Department of Ophthalmology, Chelsea and Westminster Hospital, London SW10 9NH

    EDITOR—Lipid lowering treatment in diabetes has ophthalmic benefits.1 Diabetic maculopathy is a common cause of loss of sight in diabetic patients and is characterised by retinal oedema and lipid exudates. The use of atorvastatin in diabetic maculopathy has recently been shown in a randomised controlled trial to decrease visible lipid exudates and …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe